All theories

STD Epidemic Basket

“i sexually transmitted diseases will become widespread in the general population within the next few years,”

stdhealthcarediagnosticstelehealthby anon · last month

The thesis predicts a rapid rise in sexually transmitted diseases among the general population, which would drive massive demand for diagnostics, treatments, and prevention. Companies directly involved in testing, vaccine development, and telehealth services are positioned to benefit. We concentrate on those with the most direct exposure to infectious disease management and consumer healthcare access.

Holdings
8
Largest
20%
Pillars
3
Revisions
1

Connect a wallet to launch this theory as a vault on Robinhood Chain. You sign it, so the vault is yours to revise.

How it breaks down

Diagnostics and Testing

47%

Companies providing advanced testing and diagnostic capabilities to identify and monitor STD infections.

Treatment and Vaccines

37%

Pharmaceutical firms developing vaccines and therapeutics to combat STD pathogens.

Healthcare Access

16%

Entities enabling broader access to healthcare services and financing, crucial during a widespread health crisis.

Holdings

8

Every position, why it is here, and its token on chain. Weights sum to exactly 100%.

  • ABCLAbCellera Biologics Inc.20%

    AbCellera's antibody discovery platform could accelerate development of treatments or prophylactics for emerging STD strains.

    0x3139…0B0e
  • HIMSHims & Hers Health, Inc.18%

    Hims & Hers offers discreet telehealth consultations and at-home testing kits, which would become essential as STD rates climb.

    0xCceE…3D09
  • MRNAModerna, Inc.15%

    Moderna's mRNA technology can be rapidly repurposed to create vaccines against new or resistant STD pathogens.

    0x43B0…2155
  • PFEPfizer Inc.12%

    Pfizer's extensive portfolio of antibiotics and vaccines positions it to supply treatments for bacterial STDs and potential vaccine candidates.

    0x7066…F51e
  • LLYEli Lilly10%

    Eli Lilly's research in infectious diseases and large-scale manufacturing could be leveraged for STD therapeutics.

    0x8005…00ea
  • TEMTempus AI, Inc.9%

    Tempus AI's data-driven diagnostics platform could improve detection and tracking of STD outbreaks.

    0xB1CC…1793
  • CLOVClover Health Investments, Corp.8%

    Clover Health's focus on value-based care and telehealth could expand access to STD testing and treatment for underserved populations.

    0x6220…dDd0
  • SOFISoFi Technologies8%

    SoFi's digital banking platform could facilitate payments for healthcare services, though its main relevance is indirect via consumer financial health.

    0x98E7…A926

What breaks this

Written by the same model that built the basket, and not edited to sound better.

  • 01The thesis may not materialize if public health measures effectively control STD spread, reducing demand for related products.
  • 02Regulatory hurdles could delay approval of new diagnostics or treatments, limiting revenue growth.
  • 03Competition from existing generic drugs or vaccines could cap pricing power for new entrants.
  • 04A shift in focus to other infectious diseases could divert resources away from STD-specific innovations.

Changelog

1

Every revision to this basket, who made it, and when. A theory is allowed to change its mind in public.

  1. by the modelSep 6, 2026

    Basket created from the thesis. 8 holdings.

How this basket was made

Source
Generated
Model
deepseek-chat
Chain
Robinhood Chain · 4663
Created
Sep 6, 2026

The model was given the full list of equities tokenized on Robinhood Chain and could only pick from it. Token addresses were attached afterwards from that same list, so a ticker the model invented would have been dropped rather than shown here. This is not investment advice and it has not been backtested.